These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25237458)

  • 1. Prognostic factors for urachal cancer: a bayesian model-averaging approach.
    Kim IK; Lee JY; Kwon JK; Park JJ; Cho KS; Ham WS; Hong SJ; Yang SC; Choi YD
    Korean J Urol; 2014 Sep; 55(9):574-80. PubMed ID: 25237458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
    Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
    Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
    Limonnik V; Samiei A; Abel S; Wegner RE; Vemana G; Mao SS
    Cancer Med; 2023 Feb; 12(3):2752-2760. PubMed ID: 36069175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant urachal neoplasms: A population-based study and systematic review of literature.
    Mylonas KS; O Malley P; Ziogas IA; El-Kabab L; Nasioudis D
    Urol Oncol; 2017 Jan; 35(1):33.e11-33.e19. PubMed ID: 27592530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.
    Zhang H; Jiang H; Wu Z; Fang Z; Fan J; Ding Q
    Int Urol Nephrol; 2013 Feb; 45(1):107-11. PubMed ID: 23054322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options and prognostic risk factors for urachal carcinoma: A multicetnter retrospective study.
    Ke C; Xu L; Wang M; Wang Y; Zhou Q; Chen J; Wang Z; Wang S; Hu Z; Yang C
    Urol Oncol; 2023 Jan; 41(1):50.e1-50.e9. PubMed ID: 36283930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes.
    Duan F; Zhai W; Zhang B; Guo S
    Cancer Med; 2020 Jun; 9(12):4166-4174. PubMed ID: 32329250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database.
    Davaro F; Schaefer J; May A; Raza J; Siddiqui S; Hamilton Z
    World J Urol; 2019 Mar; 37(3):497-505. PubMed ID: 30030660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urachal carcinoma: clinicopathological features, treatment and outcome.
    Kumar N; Khosla D; Kumar R; Mandal AK; Saikia UN; Kapoor R; Singh SK; Sharma SC
    J Cancer Res Ther; 2014; 10(3):571-4. PubMed ID: 25313741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Shao G; Xu C; Liu J; Li X; Li L; Li X; Zhang X; Fan Y; Zhou L
    Urol Int; 2022; 106(2):199-208. PubMed ID: 34515250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Niu HT; Dong P; Wang JN; Huang J; Zeng YX
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1923-5. PubMed ID: 27373362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
    Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
    Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage.
    Buchner A; Grimm T; Schneevoigt BS; Wittmann G; Kretschmer A; Jokisch F; Grabbert M; Apfelbeck M; Schulz G; Gratzke C; Stief CG; Karl A
    Scand J Urol; 2017 Apr; 51(2):130-136. PubMed ID: 28332428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.